Patients with PsA who are treated with CTT are not at a greater risk for serious or opportunistic infections compared with standard therapy.
The PSAs, which will be distributed in English and Spanish and include the voices of local children, cover the dangers of ...
Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...
Combining enzalutamide with standard hormone therapy cut the risk of prostate cancer death by over 40% in a clinical trial.
Dr. Leanne Woods-Burnham of Morehouse School of Medicine discusses the urgent need for Black men to push for early cancer ...
According to PC enthusiast and IgorsLab founder Igor Wallossek, the SGT-4 thermal paste marketed by South Korean company Amech contains an unstable, reactive compound that is ...
A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...
Background Data on cardiorespiratory fitness (CRF) in psoriatic arthritis (PsA) are scarce. This study aimed to determine the ...
Statistics, and the standard deviation of our tests, mean that if you order a complete metabolic profile, a lipid panel, a ...
Disease activity and multimorbidity among patients in the US with PsA varied based on geographic region, socioeconomic deprivation, race, and gender.
In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results